BR0013665A - Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite - Google Patents

Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite

Info

Publication number
BR0013665A
BR0013665A BR0013665-4A BR0013665A BR0013665A BR 0013665 A BR0013665 A BR 0013665A BR 0013665 A BR0013665 A BR 0013665A BR 0013665 A BR0013665 A BR 0013665A
Authority
BR
Brazil
Prior art keywords
histacaline
protein
treating
pharmaceutical composition
conjunctivitis
Prior art date
Application number
BR0013665-4A
Other languages
English (en)
Inventor
Patricia Anne Nuttall
Guido Christiaan Paesen
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Publication of BR0013665A publication Critical patent/BR0013665A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polarising Elements (AREA)
  • Surface Treatment Of Glass (AREA)

Abstract

"USO DE UMA PROTEìNA HISTACALINA, COMPOSIçãO FARMACêUTICA, E, MéTODO DE TRATAR OU IMPEDIR CONJUNTIVITE". A presente invenção refere-se à verificação de que várias proteínas isoladas de carrapatos são eficazes no tratamento da conjuntivite. Estas proteínas podem muito adequadamente ser aplicadas topicamente a uma área afetada e são eficazes para melhorar os sintomas desta condição.
BR0013665-4A 1999-09-01 2000-08-24 Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite BR0013665A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920674.0A GB9920674D0 (en) 1999-09-01 1999-09-01 Treatment of conjunctivitis
PCT/GB2000/003282 WO2001015719A2 (en) 1999-09-01 2000-08-24 Treatment of conjunctivitis

Publications (1)

Publication Number Publication Date
BR0013665A true BR0013665A (pt) 2002-05-14

Family

ID=10860170

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013665-4A BR0013665A (pt) 1999-09-01 2000-08-24 Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite

Country Status (17)

Country Link
US (1) US6737399B2 (pt)
EP (1) EP1207898B1 (pt)
JP (1) JP2003508445A (pt)
CN (1) CN1382057A (pt)
AT (1) ATE289203T1 (pt)
AU (1) AU780773B2 (pt)
BR (1) BR0013665A (pt)
CA (1) CA2382473A1 (pt)
DE (1) DE60018192T2 (pt)
DK (1) DK1207898T3 (pt)
ES (1) ES2235930T3 (pt)
GB (1) GB9920674D0 (pt)
HK (1) HK1046362B (pt)
MX (1) MXPA02001807A (pt)
NZ (1) NZ517218A (pt)
PT (1) PT1207898E (pt)
WO (1) WO2001015719A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
GB0809279D0 (en) * 2008-05-21 2008-06-25 Varleigh Ltd Histamine binding protein
KR102789464B1 (ko) * 2015-09-25 2025-04-03 오코겐, 인크. 란피르나제 및/또는 암피나제를 사용하는 바이러스성 결막염의 치료
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2236807T3 (es) * 1996-05-18 2005-07-16 Evolutec Limited Moleculas de union de aminas vasoactivas.
DE69836761D1 (de) * 1997-11-26 2007-02-08 Evolutec Ltd Histamine und serotonine bindende moleküle

Also Published As

Publication number Publication date
HK1046362A1 (en) 2003-01-10
DK1207898T3 (da) 2005-06-13
ATE289203T1 (de) 2005-03-15
WO2001015719A3 (en) 2001-05-10
US6737399B2 (en) 2004-05-18
EP1207898A2 (en) 2002-05-29
NZ517218A (en) 2004-10-29
AU780773B2 (en) 2005-04-14
CA2382473A1 (en) 2001-03-08
AU6713900A (en) 2001-03-26
WO2001015719A2 (en) 2001-03-08
JP2003508445A (ja) 2003-03-04
US20020151499A1 (en) 2002-10-17
DE60018192T2 (de) 2005-12-29
DE60018192D1 (de) 2005-03-24
MXPA02001807A (es) 2003-07-14
PT1207898E (pt) 2005-05-31
GB9920674D0 (en) 1999-11-03
HK1046362B (en) 2005-09-02
ES2235930T3 (es) 2005-07-16
EP1207898B1 (en) 2005-02-16
CN1382057A (zh) 2002-11-27

Similar Documents

Publication Publication Date Title
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
NO20025450D0 (no) Ny farmasöytisk sammensetning
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
EP1416799A4 (en) METHOD AND COMPOSITIONS FOR TREATING MUSHROOM INFECTIONS
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ATE305311T1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
WO2003093419A3 (en) Preventing secondary lymphedema with vegf-d dna
DE69431603D1 (de) Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
DE60018192D1 (de) Behandlung von konjunktivitis mit histacalin proteinen
PT1207899E (pt) Tratamento da rinite alergica com certas proteinas de ligacao de aminas vasoactivas
DE69721484D1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
NO20030137D0 (no) Fremgangsmåte for behandling av ustabil angina pectoris
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
EP1349548A4 (en) METHOD AND COMPOSITIONS FOR TREATING PERIODONTOSIS
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: EVOLUTEC LIMITED (GB)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060062216/RJ DE 03/05/2006.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.